SkinHealth Systems SKIN Cash Flow Statement (2020-2026)

NASDAQ SKIN
$0.74 +0.05 (+7.61%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

SkinHealth Systems Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

SkinHealth Systems reported cash from operations of $2.67M and free cash flow of $2.24M for the quarter ended Jun 2026, down 72.3% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-215.15M-20.97M31.45M6.29M-0.08M6.56M-20.22M3.37M-73.84M-9.43M-0.64M0.25M-18.29M-10.33M-10.10M19.72M-11.04M-8.09M-6.61M-2.67M
Share-based CompensationStock Comp.
133.03M7.05M6.38M7.45M7.62M3.58M8.52M8.19M2.26M6.64M6.50M7.71M5.85M3.48M5.31M2.46M3.58M2.08M2.90M
Deferred Taxes
-1.86M1.57M0.03M-1.82M-0.28M0.28M0.33M-1.41M-1.03M-1.11M1.89M-3.50M-0.27M1.08M2.08M-0.67M-0.52M0.07M
Gains from Investment SecuritiesGains Investment
199.31M0.30M-52.05M-15.19M-4.28M-6.82M9.08M-11.59M-5.86M-3.56M1.46M-4.04M-0.42M-0.07M-0.35M0.21M-0.21M-0.14M
Asset Writedowns and ImpairmentWritedown
0.11M0.38M0.67M1.36M3.67M-0.56M3.34M1.06M18.80M6.37M5.48M13.82M3.40M5.34M0.74M1.74M1.17M3.58M0.54M0.20M
Cash from OperationsCash from Ops.
0.30M3.28M-38.47M-31.34M-31.40M-5.39M-13.01M21.97M17.96M-5.17M-16.85M6.20M10.31M16.47M3.00M9.65M9.65M15.20M-5.55M2.67M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.33M2.40M1.05M1.23M1.26M1.01M
Amortization of Deferred ChargesAmort. Deferred Charges
1.06M1.10M1.10M1.06M1.06M1.06M1.06M1.06M0.95M0.80M0.79M0.79M0.79M0.85M0.98M1.01M1.01M0.99M
Change in Working Capital
Change in ReceivablesChange Receivables
-3.80M13.72M14.15M20.26M6.22M-8.61M-4.79M4.93M-6.14M-10.51M-5.88M-4.62M-2.85M-7.46M-3.99M1.71M-2.49M-0.39M-2.49M-0.88M
Change in InventoryChange Inventory
2.27M4.79M11.49M27.11M33.53M12.23M13.90M-11.30M-6.03M26.04M11.08M-4.51M0.90M3.03M-3.76M-5.33M-2.02M-4.68M0.14M-0.60M
Change in Account PayablesChange Payables
-5.68M18.57M-2.66M10.34M-0.62M-7.32M
Change in Accured ExpensesChange Accured Exp.
6.58M9.16M-6.64M15.09M-6.44M-4.97M-3.83M13.07M40.88M-6.12M-20.79M-17.90M-0.81M-4.28M-5.73M-3.99M2.60M-0.06M-9.56M12.66M
Change in TaxesChange Taxes
1.42M-2.39M3.91M-1.68M-1.39M-0.17M
Other Working Capital ChangesOther WC Changes
2.53M2.08M3.62M3.85M2.09M2.33M3.47M-0.29M1.95M2.90M2.67M1.88M2.00M1.83M2.33M0.66M1.96M1.84M
Investing Activities
Capital ExpendituresCapex
0.15M6.34M3.15M2.43M4.30M0.97M2.32M1.30M0.17M0.03M0.34M0.33M0.00M0.07M0.04M0.09M0.03M0.14M0.22M0.43M
Acquisitions
17.98M
Cash from Investing ActivitiesCash from Investing
-20.08M-8.53M-3.42M-4.88M-7.74M-2.82M-21.68M-3.22M-4.44M-2.17M-1.80M-2.04M-2.09M-0.86M-1.15M-1.55M-1.08M-1.38M-1.65M-1.21M
Financing Activities
Other financing activitiesOther financing
-0.73M-169.42M-0.23M-0.36M-0.30M
Cash from Financing ActivitiesCash from Financing
637.78M188.21M-0.78M-1.98M-100.00M-102.48M-2.19M-1.55M-2.35M-31.36M-58.62M-98.75M-0.20M-0.77M-0.25M-173.36M-0.80M-0.51M-20.91M-0.22M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Exchange Rate EffectFX Effect
-0.84M0.30M0.03M-0.07M2.38M-5.32M0.97M0.24M-1.46M2.28M-1.12M-0.50M1.33M-3.67M1.37M4.24M-0.36M-0.03M-0.21M0.47M
Change in Cash
617.99M182.96M-42.68M-38.19M-139.14M-110.70M-36.89M17.20M11.18M-38.70M-77.27M-94.59M8.02M14.84M1.60M-165.27M7.76M13.30M-28.11M1.24M
Free Cash FlowFCF
0.15M-3.06M-41.62M-33.76M-35.70M-6.36M-15.33M20.66M17.79M-5.20M-17.20M5.87M10.31M16.40M2.95M9.55M9.62M15.06M-5.78M2.24M
Net Cash FlowNCF
617.99M182.96M-42.68M-38.19M-139.14M-110.70M-36.89M17.20M11.18M-38.70M-77.27M-94.59M8.02M14.84M1.60M-165.27M7.76M13.30M-28.11M1.24M